2026 Pharmaceutical Industry Insights

As we enter 2026, pharmaceutical advertising is undergoing a fundamental transformation. Pharma TV ad spend dropped 12% year-over-year, as brands shift toward precision targeting and audiences now cluster into distinct behavioral groups.

Today's pharmaceutical marketers face a new reality: reaching the right patient matters more than reaching the most patients. For brands navigating this shift, understanding these lifestyle-driven behaviors is essential to achieving efficient reach and driving meaningful patient engagement.

Download Samba TV's new Pharmaceutical Industry Insights report to discover actionable strategies for your 2026 media planning, including:

• Why major categories like Weight Loss & Diabetes cut TV ads by 19% while Cardiovascular Health surged 17%

• How Tremfya's 313% impression growth reveals when mass TV still drives market disruption

• What the shift by Dupixent (-41%) and Skyrizi (-8%) tells us about the pivot from awareness to precision

• How lifestyle interests now define pharmaceutical audiences and media strategies

• How linking TV viewership to online behavior reveals patient intent at the moment it matters most

‍